Turkey Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare)
|
Major Players
|
Turkey Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Turkey was valued at USD 27.06 million in 2025 and is estimated at USD 27.98 million in 2026.
- The market size is expected to grow to USD 31.42 million by 2032.
- Market to register a CAGR of around 2.16% during 2026-32.
- Product Shares
- Topical analgesics/anaesthetic grabbed market share of 70%.
- Competition
- More than 5 companies are actively engaged in producing analgesics in Turkey.
- Top 5 companies acquired around 75% of the market share.
- Johnson & Johnson Sihhi Malzeme San ve Tic AS, GlaxoSmithKline Ilaclari Sanayi AS, Kurtsan Ilaclari AS, Sanli Ilac Sanayi AS, Bayer Turk Kimya Sanayi Ltd Sti etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 80% of the market.
Turkey Analgesics Market Outlook
Turkey analgesics market size was valued at USD 27.06 million in 2025 and is projected to grow from USD 27.98 million in 2026 to USD 31.42 million by 2032, exhibiting a CAGR of 2.16% during the forecast period. Growth is supported by positive demand for pain relief products, with stronger momentum coming from changing daily lifestyles, rising self care habits, and steady need for convenient solutions for routine pain management.
As active lifestyles are becoming more popular in Turkey through the increase of outdoor recreation, exercise, and sporting activities the demand for products for muscle strains and aches, as well as aches and other small injuries is increasing. In addition, stronger growth in the self medication behaviour of consumers continues to drive the demand for analgesics as many consumers continue to feel more comfortable treating mild pain such as headaches, migraines, backaches and joint discomfort without first consulting a physician.
Topical analgesics/anaesthetics represent the largest product category with approximately 70% due to the ease of application and effectiveness of treatment for both sports injuries, back soreness, and other minor body discomfort. The strength of the topical analgesics/anaesthetic category is indicative of the increasing number of more physically active consumers and increased incidence of physically related discomfort being experienced on a regular basis. At the same time, the topical analgesics/anaesthetic category is experiencing some pressure from slowing growth in the sale of children’s products related to pain relief due to declining fertility rates impacting the size of the future consumer base for child specific pain relief products.
In terms of sales channels, retail offline continue to dominate the marketplace with approximately 80% share of total sales, as consumers still use easily accessible, reputable, and promptly available traditional pharmacies to purchase their analgesics. Therefore, the regulations associated with traditional pharmacies continue to provide consumers and manufacturers with a reliable network for the purchase of analgesics, while the growing level of confidence associated with using digital formats will continue to help shape how consumers purchase analgesics. Rising internet use and stronger comfort with independent pain management are helping support wider visibility and use of OTC pain relief products across the country.

Turkey Analgesics Market Growth DriverActive Lifestyles Lift Everyday Pain Relief Demand
More active routines are supporting analgesics demand in Turkey, especially for products used for muscle strains, aches, and minor sports related discomfort. As outdoor activity, fitness, and general health awareness remain important, more consumers need quick and practical pain relief for short term injuries and body pain. This keeps topical and everyday OTC pain relief relevant in daily self care.
Official data reflects this wider sports base. The Ministry of Youth and Sports states that the number of licensed athletes in Turkey reaches 16,678,264 as of October 2024, while Turkish athletes win 6,775 medals in international competitions. This broad participation in sports and physical activity supports regular need for pain relief products linked to active lifestyles.
Turkey Analgesics Market ChallengeFalling Births Limit Paediatric Demand
A weaker birth trend is creating a challenge for analgesics demand in paediatric categories in Turkey. Lower newborn volumes reduce the size of the consumer base for child specific pain and fever products, while some households also shift toward adjusting adult doses instead of buying separate paediatric formats. This makes it harder for dedicated children’s analgesics to build stronger momentum.
The latest official figures already show this pressure. Turkish Statistical Institute (TÜİK) reports that the number of births in the first seven months of 2025 falls by 8.3% year on year to 503,765. This decline directly affects the long term volume base for paediatric pain relief, even as broader analgesics demand remains supported by adult use.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Turkey Analgesics Market TrendSelf-Care Confidence Builds Through Digital Reach
A stronger self care pattern is becoming more visible in Turkey as consumers feel more comfortable managing mild pain on their own. This supports OTC analgesics for headaches, migraines, back pain, and joint discomfort, especially when buyers want fast relief without starting with a doctor visit. Easier access to digital information and connected services is helping this habit become more established.
The digital base behind this shift is expanding. Information and Communication Technologies Authority (BTK) reports 97,361,083 total internet subscriptions and 96.5 million mobile subscribers in Q2 2025, while TÜİK shows internet use among people aged 65-74 rises from 19.8% in 2019 to 46.9% in 2024. Wider digital confidence supports more informed and more independent everyday pain management.
Turkey Analgesics Market OpportunityAgeing Consumers Open Wider Use Cases
An ageing population is creating a clear opportunity for analgesics in Turkey. Older adults face a higher need for everyday pain management linked to joint pain, back pain, and other chronic discomforts, which supports regular demand for accessible relief products. This also creates room for brands that offer practical formats and solutions suited to longer term, routine pain management needs.
TÜİK’s latest elderly statistics show that people aged 65 and over account for 10.6% of Turkey’s population in 2024, equal to 9,112,298 people. The same release reports life expectancy at birth at 78.1 years, and expected remaining life at age 65 at 18.0 years. These figures support a broader and more sustained base for age related pain relief demand.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Turkey Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is topical analgesics/anaesthetic, holding around 70% of the Turkey analgesics market in value terms. This segment stays ahead because consumers increasingly use topical pain relief for muscle strains, sports injuries, back pain, and everyday body discomfort. Easy application and targeted relief also make these products a practical choice for active consumers and people dealing with routine physical pain.
Its strong position is supported by Turkey’s wider sports participation trend. The Ministry of Youth and Sports reports 16,678,264 licensed athletes as of October 2024, showing a broad base of consumers involved in regular physical activity. As more people stay active, the need for convenient external pain relief products remains strong, helping topical analgesics/anaesthetic maintain their leading share in the category.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, holding around 80% of the Turkey analgesics market in value terms. This channel continues to lead because consumers still rely on physical pharmacies for quick access, trusted product advice, and immediate purchase of pain relief products. Store based buying remains important for analgesics, especially when consumers want reassurance on use and product suitability.
Retail offline stays ahead because pharmacy access in Turkey remains structured around a regulated physical network. Turkish Medicines and Medical Devices Agency (TITCK) continues pharmacy placement through the Eczacı Yerleştirme Sistemi (EYS) in 2025, while the Turkish Pharmacists’ Association represents community pharmacists through 51 regional chambers. This regulated pharmacy structure keeps offline retail medicine purchasing central to the category, even as retail online continue to expand.
List of Companies Covered in Turkey Analgesics Market
The companies listed below are highly influential in the Turkey analgesics market, with a significant market share and a strong impact on industry developments.
- Johnson & Johnson Sihhi Malzeme San ve Tic AS
- GlaxoSmithKline Ilaclari Sanayi AS
- Kurtsan Ilaclari AS
- Sanli Ilac Sanayi AS
- Bayer Turk Kimya Sanayi Ltd Sti
- Abdi Ibrahim Ilac San ve Tic AS
- Honnes Saglik ve Endustriyel Urunleri AS
Competitive Landscape
In 2025, analgesics in Turkey recorded positive retail value growth, driven primarily by strong performance in topical analgesics/anaesthetic as increasing participation in outdoor activities and sports led to a rise in muscle strains, aches, and injuries. A growing self-medication culture supported demand, with consumers showing greater confidence in using OTC options such as ibuprofen and acetaminophen for mild pain including headaches, migraines, and joint discomfort, although widespread under-the-counter sales of Rx products continued to challenge OTC growth. Sanli Ilac Sanayi AS led the market with a 30.2% value share, followed by Bayer Turk Kimya Sanayi Ltd Sti at 20.7%. Demographic and lifestyle factors also played a key role, with an ageing population increasing demand due to chronic pain, while sedentary work habits and prolonged screen time contributed to neck, shoulder, and back issues, although declining birth rates limited paediatric analgesics growth and rising health consciousness supported demand for natural remedies such as menthol- and camphor-based solutions.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Turkey Analgesics Market Policies, Regulations, and Standards
- Turkey Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Turkey Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Turkey Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Turkey Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Sanli Ilac Sanayi as
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bayer Turk Kimya Sanayi Ltd Sti
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Johnson & Johnson Sihhi Malzeme San ve Tic AS
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GlaxoSmithKline Ilaclari Sanayi AS
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Kurtsan Ilaclari AS
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Abdi Ibrahim Ilac San ve Tic AS
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Honnes Saglik ve Endustriyel urunleri AS
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Others
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sanli Ilac Sanayi as
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











